The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.

Pokaži ostale verzije (2)

Bibliografski detalji
Glavni autori:	Clark, W, Jobanputra, P, Barton, P, Burls, A
Format:	Journal article
Izdano:	2004

Slični predmeti

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
od: Clark, W, i dr.
Izdano: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis.
od: Clark, W, i dr.
Izdano: (2004)

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis
od: W Clark, i dr.
Izdano: (2004-09-01)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
od: Chen, Y, i dr.
Izdano: (2006)

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
od: Chen, Y, i dr.
Izdano: (2006)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
od: Jobanputra, P, i dr.
Izdano: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
od: Jobanputra, P, i dr.
Izdano: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
od: P. Jobanputra, i dr.
Izdano: (2002-01-01)

The trials of anakinra.
od: Burls, A, i dr.
Izdano: (2004)

The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis
od: L. Riente
Izdano: (2011-09-01)

Hepatotoxicity of tocilizumab and anakinra in rheumatoid arthritis: management decisions
od: Mahamid M, i dr.
Izdano: (2011-10-01)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
od: Ruiz Garcia, V, i dr.
Izdano: (2014)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
od: Barton, P, i dr.
Izdano: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.
od: Barton, P, i dr.
Izdano: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis
od: P Barton, i dr.
Izdano: (2004-03-01)

A survey of British rheumatologists' DMARD preferences for rheumatoid arthritis.
od: Jobanputra, P, i dr.
Izdano: (2004)

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis - Introduction
od: Barton, P, i dr.
Izdano: (2004)

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
od: Ruiz Garcia, V, i dr.
Izdano: (2011)

Hepatotoxicity due to tocilizumab and anakinra in rheumatoid arthritis: two case reports
od: Mahamid M, i dr.
Izdano: (2011-09-01)

Severe infection in patients with rheumatoid arthritis taking anakinra, rituximab, or abatacept: a systematic review of observational studies
od: Vanderlea Poeys Cabral, i dr.

The use of anakinra in a patient with gout and long-term follow-up of rheumatoid arthritis
od: E. V. Cheremushkina, i dr.
Izdano: (2023-07-01)

Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis
od: S. Todesco, i dr.
Izdano: (2011-09-01)

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA)
od: Bullement A, i dr.
Izdano: (2021-09-01)

Etanercept for the treatment of rheumatoid arthritis.
od: Lethaby, A, i dr.
Izdano: (2013)

Infliximab for the treatment of rheumatoid arthritis.
od: Blumenauer, B, i dr.
Izdano: (2002)

Etanercept for the treatment of rheumatoid arthritis
od: Blumenauer, B, i dr.
Izdano: (2004)

Etanercept for the treatment of rheumatoid arthritis.
od: Blumenauer, B, i dr.
Izdano: (2003)

Problems in the treatment of rheumatoid arthritis and prospects for the use of an IL-1 inhibitor (Anakinra). (Resolution of the Expert Council, May 19, 2022)
od: article Editorial
Izdano: (2022-11-01)

Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation
od: K Malottki, i dr.
Izdano: (2011-03-01)

Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
od: Y Chen, i dr.
Izdano: (2008-04-01)

Anakinra treatment in patients with systemic-onset juvenil idiopathic arthritis: “The Valencia Experience”
od: Montesinos B, i dr.
Izdano: (2011-09-01)

PB2045: USE OF ANAKINRA IN THE TREATMENT OF ADULT HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A SYSTEMATIC REVIEW
od: Ali Eshaghpour, i dr.
Izdano: (2023-08-01)

The cost-effectiveness of biologics for the treatment of rheumatoid arthritis: a systematic review.
od: Jaana T Joensuu, i dr.
Izdano: (2015-01-01)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
od: Burls, A, i dr.
Izdano: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
od: Burls, A, i dr.
Izdano: (2002)

Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation
od: A. Burls, i dr.
Izdano: (2002-01-01)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
od: Clark, W, i dr.
Izdano: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
od: Clark, W, i dr.
Izdano: (2003)

Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
od: W. Clark, i dr.
Izdano: (2003-01-01)

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): randomised controlled trial with economic analysis
od: Alison Hammond, i dr.
Izdano: (2021-01-01)